Bluetongue is considered as a potential bioweapon because of the following factors:
There is a risk of bluetongue to any country with competent vectors.
Historically, BTV has produced devastating ovine epizootics and been difficult to eliminate and control in bovine populations.
Viremic animals cannot be distinguished from nontransmitting animals.
Widespread infection would result in significant economic costs from lost trade of germ plasm and animal products and regulatory costs would increase.
Source: USAHA
***********************************************************
A ProMED-mail post
ProMED-mail is a program of the
International Society for Infectious Diseases
Date: Sun 16 Oct 2011
Source: Ministry of Environment and Rural and Marine Affairs, Spain,
Veterinary Health Alert Network news release [in Spanish, trans.
submitter SZ, edited]
1st bluetongue outbreak in 2011-2012 season reported in Caceres
province
---------------------------------------------------------------
The National Reference Laboratory in Algete has confirmed renewed
circulation of bluetongue virus [BTV] serotype 1 in an unvaccinated
sentinel cattle holding in Plasencia (Caceres), which is part of the
National BT Disease Surveillance Program.
The Official Veterinary Services of the Junta de Extremadura have
reported detection of 10 animals positive for BTV-1 (see map at
The confirmation of this case of bluetongue means a reappearance of
the disease in Spain since the end of the last disease (vector
activity) season.
During 2010, a total of 91 outbreaks were reported, of which 80 were
of BTV-1, 10 of BTV-4, and one focus of BTV-8.
The reappearance of the disease has led to the strengthening of BT
control measures. These measures involve, in the affected area,
increased surveillance and biosecurity measures, vector control, and
the recommendation for vaccination of susceptible species.
Official notification of the new outbreak has been sent to the
European Commission, OIE, and other autonomous communities and sectors
involved.
--
communicated by:
Sabine Zentis
Castleview Pedigree English Longhorns
Gut Laach
52385 Nideggen
Germany
[BTV-1 was detected in the same location/region during the same season
last year (2010); see slide 3 in Spain's presentation to EU's SCOFCAH
(Standing Committee on the Food Chain and Animal Health, UK), "Updates
2009-2010 and Disease Future: Perspective in Spain", available at
This may be indicative of the endemic status (or overwintering) of
this virus in Spain, though reintroduction from Northern Africa is not
excluded. BTV-1 and BTV-4 are currently circulating in Morocco (see
commentary in ProMED-mail 20111008.3023). - Mod.AS
A HealthMap/ProMED-mail interactive map of Spain can be seen at
[see also:
Bluetongue, sheep - Algeria (02): (AN), spread 20111008.3023
2010
---
Bluetongue - Europe (06): Spain (AN) st 8, susp, RFI 20101126.4267
Bluetongue - Europe (04): Spain, serotypes 1, 4 20101016.3751
Bluetongue - Europe (03): Spain (AN), BTV-4, OIE 20101006.3627]
.................................................arn/mj/sh
*##########################################################*
************************************************************
ProMED-mail makes every effort to verify the reports that
are posted, but the accuracy and completeness of the
information, and of any statements or opinions based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by ProMED-mail. ISID
and its associated service providers shall not be held
responsible for errors or omissions or held liable for any
damages incurred as a result of use or reliance upon posted
or archived material.
************************************************************
Donate to ProMED-mail. Details available at:
************************************************************
Visit ProMED-mail's web site at
Send all items for posting to: promed@promedmail.org (NOT to
an individual moderator). If you do not give your full name
name and affiliation, it may not be posted. You may unsub-
scribe at
For assistance from a human being, send mail to:
############################################################
##############################
No comments:
Post a Comment